Inicio
Autor Quintero Vega, Guillermo E
|
|
Documentos disponibles escritos por este autor (2)
Clasificado(s) por (Año de edición descendente) Refinar búsquedaCharacteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study / Kenny Mauricio Gálvez Cárdenas ; Laura María Díaz Correa ; Sossa Melo, Claudia ; Abello Polo, Virginia ; Salazar, Luis A. ; Peña, Angela M ; González, María Luna ; Cuervo Lozada, Diana ; Quintero Vega, Guillermo E ; Daza, Jorge ; Omaña Orduz, Olga Paola ; Mantilla, William ; Perdomo, Iván ; Guerrero Burbano, Paola Andrea ; Herrera, Juan Manuel ; Idrobo, Henry ; Rodríguez Veiga, Rebeca ; Correa Correa, Mario Ernesto ; Lobatón, José ; Bermúdez, Carlos Daniel ; Pedraza Morales, Julian Eduardo ; Serrano Casas, Juan Carlos ; Jaramillo, Francisco ; Gómez, Rigoberto ; Rosales, Carmen ; Solano, María Helena ; Varón, Carlos ; Martínez Cuadrón, David ; Montesinos, Pau
Título : Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study Tipo de documento : documento electrónico Autores : Kenny Mauricio Gálvez Cárdenas, Autor ; Laura María Díaz Correa, Autor ; Sossa Melo, Claudia, Autor ; Abello Polo, Virginia, Autor ; Salazar, Luis A., Autor ; Peña, Angela M, Autor ; González, María Luna, Autor ; Cuervo Lozada, Diana, Autor ; Quintero Vega, Guillermo E, Autor ; Daza, Jorge, Autor ; Omaña Orduz, Olga Paola, Autor ; Mantilla, William, Autor ; Perdomo, Iván, Autor ; Guerrero Burbano, Paola Andrea, Autor ; Herrera, Juan Manuel, Autor ; Idrobo, Henry, Autor ; Rodríguez Veiga, Rebeca, Autor ; Correa Correa, Mario Ernesto, Autor ; Lobatón, José, Autor ; Bermúdez, Carlos Daniel, Autor ; Pedraza Morales, Julian Eduardo, Autor ; Serrano Casas, Juan Carlos, Autor ; Jaramillo, Francisco, Autor ; Gómez, Rigoberto, Autor ; Rosales, Carmen, Autor ; Solano, María Helena, Autor ; Varón, Carlos, Autor ; Martínez Cuadrón, David, Autor ; Montesinos, Pau, Autor Fecha de publicación : 2025 Títulos uniformes : Annals of Hematology Idioma : Inglés (eng) Palabras clave : Acute myeloid leukemia; Elderly patients; Overall survival; Treatment outcomes. Resumen : There is a limited information available on the clinical characteristics, treatment patterns and outcomes on older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 patients over 60 years of age diagnosed with AML in Colombia, using data from RENEHOC-PETHEMA registry, from 2009 to 2023. The median age at diagnosis was 70 years (Range:60-98), 55% were men, 61% had an ECOG Mención de responsabilidad : Claudia Sossa-Melo, Virginia Abello-Polo, Luis A Salazar, Angela M Peña, María Luna-González 4, Diana Cuervo-Lozada, Guillermo E Quintero-Vega, Jorge Daza, Olga Paola Omaña-Orduz, William Mantilla, Iván Perdomo, Kenny Galvez, Laura María Díaz-Correa, Paola Andrea Guerrero-Burbano, Juan Manuel Herrera, Henry Idrobo, L M Gaviria, Mario Ernesto Correa-Correa, José Lobatón, Carlos Daniel Bermúdez, Julian Eduardo Pedraza-Morales, Juan Carlos Serrano-Casas, Francisco Jaramillo, Rigoberto Gómez, Carmen Rosales, María Helena Solano, Carlos Varón, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, Pau Montesinos. Referencia : Ann Hematol . 2025 Jan;104(1):369-381 DOI (Digital Object Identifier) : 10.1007/s00277-024-06120-0 PMID : 39815122 Derechos de uso : CC BY-NC-ND En línea : https://pubmed-ncbi-nlm-nih-gov.consultaremota.upb.edu.co/39815122/ Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study [documento electrónico] / Kenny Mauricio Gálvez Cárdenas, Autor ; Laura María Díaz Correa, Autor ; Sossa Melo, Claudia, Autor ; Abello Polo, Virginia, Autor ; Salazar, Luis A., Autor ; Peña, Angela M, Autor ; González, María Luna, Autor ; Cuervo Lozada, Diana, Autor ; Quintero Vega, Guillermo E, Autor ; Daza, Jorge, Autor ; Omaña Orduz, Olga Paola, Autor ; Mantilla, William, Autor ; Perdomo, Iván, Autor ; Guerrero Burbano, Paola Andrea, Autor ; Herrera, Juan Manuel, Autor ; Idrobo, Henry, Autor ; Rodríguez Veiga, Rebeca, Autor ; Correa Correa, Mario Ernesto, Autor ; Lobatón, José, Autor ; Bermúdez, Carlos Daniel, Autor ; Pedraza Morales, Julian Eduardo, Autor ; Serrano Casas, Juan Carlos, Autor ; Jaramillo, Francisco, Autor ; Gómez, Rigoberto, Autor ; Rosales, Carmen, Autor ; Solano, María Helena, Autor ; Varón, Carlos, Autor ; Martínez Cuadrón, David, Autor ; Montesinos, Pau, Autor . - 2025.
Obra : Annals of Hematology
Idioma : Inglés (eng)
Palabras clave : Acute myeloid leukemia; Elderly patients; Overall survival; Treatment outcomes. Resumen : There is a limited information available on the clinical characteristics, treatment patterns and outcomes on older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 patients over 60 years of age diagnosed with AML in Colombia, using data from RENEHOC-PETHEMA registry, from 2009 to 2023. The median age at diagnosis was 70 years (Range:60-98), 55% were men, 61% had an ECOG Mención de responsabilidad : Claudia Sossa-Melo, Virginia Abello-Polo, Luis A Salazar, Angela M Peña, María Luna-González 4, Diana Cuervo-Lozada, Guillermo E Quintero-Vega, Jorge Daza, Olga Paola Omaña-Orduz, William Mantilla, Iván Perdomo, Kenny Galvez, Laura María Díaz-Correa, Paola Andrea Guerrero-Burbano, Juan Manuel Herrera, Henry Idrobo, L M Gaviria, Mario Ernesto Correa-Correa, José Lobatón, Carlos Daniel Bermúdez, Julian Eduardo Pedraza-Morales, Juan Carlos Serrano-Casas, Francisco Jaramillo, Rigoberto Gómez, Carmen Rosales, María Helena Solano, Carlos Varón, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, Pau Montesinos. Referencia : Ann Hematol . 2025 Jan;104(1):369-381 DOI (Digital Object Identifier) : 10.1007/s00277-024-06120-0 PMID : 39815122 Derechos de uso : CC BY-NC-ND En línea : https://pubmed-ncbi-nlm-nih-gov.consultaremota.upb.edu.co/39815122/ Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD002333 AC-2025-016 Archivo digital Producción Científica Artículos científicos Disponible
Título : Healthcare Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study Tipo de documento : documento electrónico Autores : Kenny Mauricio Gálvez Cárdenas, Autor ; Hungria, Vania, Autor ; Gaiolla, Rafael, Autor ; Remaggi, Guillermina, Autor ; Schutz, Natalia, Autor ; Bittencourt, Rosane, Autor ; Maiolino, Angelo, Autor ; Quintero Vega, Guillermo E, Autor ; Silvana Cugliari, Maria, Autor ; Tobias Braga, Walter Moises, Autor ; Colaco Villarim, Carolina, Autor ; Crusoe, Edvan, Autor ; Enrico, Alicia Ines, Autor ; Caiero, Gaston, Autor ; Bigonha, Jandey, Autor ; Lemos Moura, Fernanda, Autor ; Figueroa, Jair, Autor ; Sossa Melo, Claudia Lucia, Autor ; Lombana, Milton, Autor ; Pei, Huiling, Autor ; Fernandez, Mariana, Autor ; Saes, Jaqueline, Autor ; Trufelli, Damila Cristina, Autor Fecha de publicación : 2025 Títulos uniformes : Blood Advances Idioma : Inglés (eng) Resumen : Although systemic therapy for multiple myeloma (MM) has evolved considerably over the past 2 decades, state-of-the-art treatment is not uniformly available in Latin America. In some countries, disparities between the public and private sectors in clinical presentation, access to novel agents, and transplantation are striking, with the public sector lagging. We conducted a multicenter, observational study of patients with MM in 5 Latin American countries (Argentina, Brazil, Colombia, Mexico, and Panama). We enrolled patients aged ?18 years diagnosed with MM between January 2016 and June 2021, using data collected between May 2019 and June 2022. We categorized institutions as “public” when primarily funded by federal or local government, and “private” when financed mostly or completely by other sources. We analyzed 1029 patients, 1021 of whom could be classified into public (n = 339) and private (n = 682) institutions. These 2 groups differed in many respects, with patients from the latter having better baseline prognostic features (including eligibility to transplantation) and receiving combinations of immunomodulatory drugs and proteasome inhibitors, as well as anti-CD38 antibodies, more frequently than patients from public institutions. Among 960 patients with complete data for this analysis, the median overall survival was 44.6 months in public institutions and 53.3 months in private institutions (hazard ratio, 0.84; 95% confidence interval, 0.67-1.04; P = .109). Our results indicate diagnostic and therapeutic shortcomings in the management of MM in Latin America, with important gaps in patient profile, treatment patterns and long-term outcomes between public and private institutions. Mención de responsabilidad : Vania Hungria, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Natalia Schutz, Rosane Bittencourt, Angelo Maiolino, Guillermo Quintero, Maria Silvana Cugliari, Walter Moises Tobias Braga, Carolina Colaco Villarim, Edvan Crusoe, Alicia Ines Enrico, Gaston Caiero, Jandey Bigonha, Fernanda Lemos Moura, Jair Figueroa, Claudia Lucia Sossa Melo, Milton Lombana, Huiling Pei, Mariana Fernandez, Jaqueline Saes, Damila Cristina Trufelli. Referencia : Blood Advances Volume 9, Issue 6, 25 March 2025, Pages 1293-1302 DOI (Digital Object Identifier) : 10.1182/bloodadvances.2024013838 Derechos de uso : CC BY-NC-ND En línea : https://www.sciencedirect.com/science/article/pii/S2473952924007146 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Healthcare Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study [documento electrónico] / Kenny Mauricio Gálvez Cárdenas, Autor ; Hungria, Vania, Autor ; Gaiolla, Rafael, Autor ; Remaggi, Guillermina, Autor ; Schutz, Natalia, Autor ; Bittencourt, Rosane, Autor ; Maiolino, Angelo, Autor ; Quintero Vega, Guillermo E, Autor ; Silvana Cugliari, Maria, Autor ; Tobias Braga, Walter Moises, Autor ; Colaco Villarim, Carolina, Autor ; Crusoe, Edvan, Autor ; Enrico, Alicia Ines, Autor ; Caiero, Gaston, Autor ; Bigonha, Jandey, Autor ; Lemos Moura, Fernanda, Autor ; Figueroa, Jair, Autor ; Sossa Melo, Claudia Lucia, Autor ; Lombana, Milton, Autor ; Pei, Huiling, Autor ; Fernandez, Mariana, Autor ; Saes, Jaqueline, Autor ; Trufelli, Damila Cristina, Autor . - 2025.
Obra : Blood Advances
Idioma : Inglés (eng)
Resumen : Although systemic therapy for multiple myeloma (MM) has evolved considerably over the past 2 decades, state-of-the-art treatment is not uniformly available in Latin America. In some countries, disparities between the public and private sectors in clinical presentation, access to novel agents, and transplantation are striking, with the public sector lagging. We conducted a multicenter, observational study of patients with MM in 5 Latin American countries (Argentina, Brazil, Colombia, Mexico, and Panama). We enrolled patients aged ?18 years diagnosed with MM between January 2016 and June 2021, using data collected between May 2019 and June 2022. We categorized institutions as “public” when primarily funded by federal or local government, and “private” when financed mostly or completely by other sources. We analyzed 1029 patients, 1021 of whom could be classified into public (n = 339) and private (n = 682) institutions. These 2 groups differed in many respects, with patients from the latter having better baseline prognostic features (including eligibility to transplantation) and receiving combinations of immunomodulatory drugs and proteasome inhibitors, as well as anti-CD38 antibodies, more frequently than patients from public institutions. Among 960 patients with complete data for this analysis, the median overall survival was 44.6 months in public institutions and 53.3 months in private institutions (hazard ratio, 0.84; 95% confidence interval, 0.67-1.04; P = .109). Our results indicate diagnostic and therapeutic shortcomings in the management of MM in Latin America, with important gaps in patient profile, treatment patterns and long-term outcomes between public and private institutions. Mención de responsabilidad : Vania Hungria, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Natalia Schutz, Rosane Bittencourt, Angelo Maiolino, Guillermo Quintero, Maria Silvana Cugliari, Walter Moises Tobias Braga, Carolina Colaco Villarim, Edvan Crusoe, Alicia Ines Enrico, Gaston Caiero, Jandey Bigonha, Fernanda Lemos Moura, Jair Figueroa, Claudia Lucia Sossa Melo, Milton Lombana, Huiling Pei, Mariana Fernandez, Jaqueline Saes, Damila Cristina Trufelli. Referencia : Blood Advances Volume 9, Issue 6, 25 March 2025, Pages 1293-1302 DOI (Digital Object Identifier) : 10.1182/bloodadvances.2024013838 Derechos de uso : CC BY-NC-ND En línea : https://www.sciencedirect.com/science/article/pii/S2473952924007146 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Reserva
Reservar este documento
Ejemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD002345 AC-2025-028 Archivo digital Producción Científica Artículos científicos Disponible
